Who to call at Innate Pharma, and when
Fundz watches for the moments Innate Pharma starts buying, and tells you who to reach.
- An alert the day Innate Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Innate Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Innate Pharma. With Fundz connected, it knows.
Contract Type
partnership
Description
The partnership between Innate Pharma and Sobi is now effective following the expiration of anti-trust waiting periods. This triggers a $75 million upfront payment and initiates the TELLOMAK-3 confirmatory Phase 3 study, aiming for the first patient in Q1 2027.
Quick answer
Innate Pharma and Sobi Partnership Now Effective with $75 Million Upfront Payment (November 15, 2026). Innate Pharma is based in Marseille, Provence Alpes Côte D'azur, France.
- What agreement did Innate Pharma announce on November 15, 2026?
- The partnership between Innate Pharma and Sobi is now effective following the expiration of anti-trust waiting periods. This triggers a $75 million upfront payment and initiates the TELLOMAK-3 confirmatory Phase 3 study, aiming for the first patient in Q1 2027.
- What does Innate Pharma do?
- Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight...
- Where is Innate Pharma based?
- Innate Pharma is based in Marseille, Provence Alpes Côte D'azur, France.
- Which similar companies announced agreements around the same time?
- Pfizer (November 14, 2026), Sino Biopharmaceutical (November 13, 2026), Ocugen (November 10, 2026) and Kimia Therapeutics (November 5, 2026) also announced agreements within 45 days of Innate Pharma.
Source: Fundz verified event record.
Other recent agreements in Therapeutics and Biotechnology
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug. (November 14, 2026)
- Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026)
- Ocugen Enters Exclusive License Agreement with Celairis Therapeutics (November 10, 2026)
- Kimia Therapeutics and CStone Pharmaceuticals Collaborate on Clinical Development of KT-721 for Oncology Treatment. (November 5, 2026)
- Aarvik Therapeutics Enters Partnership with Laurus Labs for MUTTA™ ADC Development in India. (November 3, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
Related People
Agreement Insights
What this usually meansInnate Pharma signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.